Jose Refugio Torres-Nava
Overview
Explore the profile of Jose Refugio Torres-Nava including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sepulveda-Robles O, Flores-Lujano J, Nunez-Enriquez J, Jimenez-Hernandez E, Duarte-Rodriguez D, Martin-Trejo J, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075581
Background: The few epidemiologic studies of infection exposure in early life and acute leukemia (AL) risk in Latino children have yielded inconsistent results, suggesting a possible effect of ethnicity. Here,...
2.
Garcia-Solorio J, Nunez-Enriquez J, Jimenez-Olivares M, Flores-Lujano J, Flores-Espino F, Molina-Garay C, et al.
Front Oncol
. 2024 Apr;
14:1337954.
PMID: 38634053
Background: Recurrent genetic alterations contributing to leukemogenesis have been identified in pediatric B-cell Acute Lymphoblastic Leukemia (B-ALL), and some are useful for refining classification, prognosis, and treatment selection. is a...
3.
Duarte-Rodriguez D, Flores-Lujano J, McNally R, Perez-Saldivar M, Jimenez-Hernandez E, Martin-Trejo J, et al.
Front Oncol
. 2024 Feb;
14:1304633.
PMID: 38420017
Background: A heterogeneous geographic distribution of childhood acute lymphoblastic leukemia (ALL) cases has been described, possibly, related to the presence of different environmental factors. The aim of the present study...
4.
Escalante-Bautista D, Cerecedo D, Jimenez-Hernandez E, Gonzalez-Torres C, Gaytan-Cervantes J, Nunez-Enriquez J, et al.
Front Oncol
. 2024 Jan;
13:1276352.
PMID: 38269022
Background: Advances in the understanding of the pathobiology of childhood B-cell acute lymphoblastic leukemia (B-ALL) have led towards risk-oriented treatment regimens and markedly improved survival rates. However, treatment-related toxicities remain...
5.
Merida-Ortega A, Perez-Saldivar M, Espinoza-Hernandez L, Dorantes-Acosta E, Torres-Nava J, Solis-Labastida K, et al.
Front Oncol
. 2023 Sep;
13:1239147.
PMID: 37746300
Introduction: Maternal dietary consumption during pregnancy has been inconclusively associated with acute leukemia (AL) in infants, probably because epidemiological evidence has emerged mainly from the analysis of one-by-one nutrient, which...
6.
Sepulveda-Robles O, Jimenez-Hernandez E, Dominguez-Catzin V, Gomez-Flores E, Martin-Trejo J, Flores-Lujano J, et al.
Front Pediatr
. 2022 Dec;
10:946690.
PMID: 36452349
Background: The distribution of , , , , and in the pediatric population with acute myeloid leukemia (AML) in many countries of Latin America is largely unknown. Therefore, we aimed...
7.
Valenzuela-Vazquez L, Nunez-Enriquez J, Sanchez-Herrera J, Medina-Sanson A, Perez-Saldivar M, Jimenez-Hernandez E, et al.
Front Oncol
. 2022 Nov;
12:1023510.
PMID: 36419901
NK cells have unique attributes to react towards cells undergoing malignant transformation or viral infection. This reactivity is regulated by activating or inhibitory germline encoded receptors. An impaired NK cell...
8.
Flores-Lujano J, Duarte-Rodriguez D, Jimenez-Hernandez E, Martin-Trejo J, Allende-Lopez A, Penaloza-Gonzalez J, et al.
Front Public Health
. 2022 Oct;
10:918921.
PMID: 36187646
Introduction: Over the years, the Hispanic population living in the United States has consistently shown high incidence rates of childhood acute leukemias (AL). Similarly, high AL incidence was previously observed...
9.
May-Hau D, Barcenas-Lopez D, Nunez-Enriquez J, Bekker-Mendez V, Beltran-Anaya F, Jimenez-Hernandez E, et al.
Front Oncol
. 2022 Jun;
12:887766.
PMID: 35719952
Background: B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is the most frequent pediatric cancer worldwide. Despite improvements in treatment regimens, approximately 20% of the cases cannot be cured, highlighting the necessity...
10.
Mata-Rocha M, Rangel-Lopez A, Jimenez-Hernandez E, Nunez-Enriquez J, Morales-Castillo B, Sanchez-Escobar N, et al.
Front Pediatr
. 2022 Jun;
10:837656.
PMID: 35685921
is a genetic rearrangement of good prognosis in children with acute lymphoblastic leukemia (ALL). In Mexico, its prevalence is low in comparison with Caucasian populations. We developed a novel TaqMan...